| Net Cash Provided by (Used in) Financing Activities |
$94,750 |
USD |
-53% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$7,712 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
350,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
26,511,032 |
shares |
45% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$384 |
USD |
273% |
Q3 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$255 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$2,666,888 |
USD |
73% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Gross |
$2,666,888 |
USD |
73% |
Q3 2025 |
Q1 2026 |
| Depreciation |
$41,810 |
USD |
|
Q3 2025 |
Q1 2026 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
|
Q3 2024 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$1,162,635 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$7,023,798 |
USD |
|
Q2 2024 |
FY 2024 |
| Current Income Tax Expense (Benefit) |
$623,851 |
USD |
|
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
$9,467,710 |
USD |
58% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Share-based Payment Arrangement, Expense |
$263,522 |
USD |
-3.3% |
Q3 2025 |
Q1 2026 |
| Interest Expense |
$54,649 |
USD |
484% |
Q3 2025 |
Q1 2026 |